These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 26227148)

  • 21. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypothesis testing in Bayesian network meta-analysis.
    Uhlmann L; Jensen K; Kieser M
    BMC Med Res Methodol; 2018 Nov; 18(1):128. PubMed ID: 30419827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing Bayesian and frequentist approaches for multiple outcome mixed treatment comparisons.
    Hong H; Carlin BP; Shamliyan TA; Wyman JF; Ramakrishnan R; Sainfort F; Kane RL
    Med Decis Making; 2013 Jul; 33(5):702-14. PubMed ID: 23549384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sample size estimation in single-arm clinical trials with multiple testing under frequentist and Bayesian approaches.
    Zaslavsky BG; Scott J
    J Biopharm Stat; 2012; 22(4):819-35. PubMed ID: 22651117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequentist performance of Bayesian confidence intervals for comparing proportions in 2 x 2 contingency tables.
    Agresti A; Min Y
    Biometrics; 2005 Jun; 61(2):515-23. PubMed ID: 16011699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
    Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
    J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Living with p values: resurrecting a Bayesian perspective on frequentist statistics.
    Greenland S; Poole C
    Epidemiology; 2013 Jan; 24(1):62-8. PubMed ID: 23232611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effectiveness of therapeutic strategies for patients with radiculopathy: A network meta-analysis.
    Zhang X; Zhang Z; Wen J; Lu J; Sun Y; Sang D
    Mol Pain; 2018; 14():1744806918768972. PubMed ID: 29651898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extensions of the probabilistic ranking metrics of competing treatments in network meta-analysis to reflect clinically important relative differences on many outcomes.
    Mavridis D; Porcher R; Nikolakopoulou A; Salanti G; Ravaud P
    Biom J; 2020 Mar; 62(2):375-385. PubMed ID: 31661561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Bayesian Power Analysis Procedure Considering Uncertainty in Effect Size Estimates from a Meta-analysis.
    Du H; Wang L
    Multivariate Behav Res; 2016; 51(5):589-605. PubMed ID: 27485763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How trace plots help interpret meta-analysis results.
    Röver C; Rindskopf D; Friede T
    Res Synth Methods; 2024 May; 15(3):413-429. PubMed ID: 38100240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using structural equation modeling for network meta-analysis.
    Tu YK; Wu YC
    BMC Med Res Methodol; 2017 Jul; 17(1):104. PubMed ID: 28709406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Passive smoking in the workplace: classical and Bayesian meta-analyses.
    Biggerstaff BJ; Tweedie RL; Mengersen KL
    Int Arch Occup Environ Health; 1994; 66(4):269-77. PubMed ID: 7843838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequentist performances of Bayesian prediction intervals for random-effects meta-analysis.
    Hamaguchi Y; Noma H; Nagashima K; Yamada T; Furukawa TA
    Biom J; 2021 Feb; 63(2):394-405. PubMed ID: 33164247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outlier detection and influence diagnostics in network meta-analysis.
    Noma H; Gosho M; Ishii R; Oba K; Furukawa TA
    Res Synth Methods; 2020 Nov; 11(6):891-902. PubMed ID: 32921002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statistical approaches for conducting network meta-analysis in drug development.
    Jones B; Roger J; Lane PW; Lawton A; Fletcher C; Cappelleri JC; Tate H; Moneuse P;
    Pharm Stat; 2011; 10(6):523-31. PubMed ID: 22213533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Node-Splitting Generalized Linear Mixed Models for Evaluation of Inconsistency in Network Meta-Analysis.
    Yu-Kang T
    Value Health; 2016 Dec; 19(8):957-963. PubMed ID: 27987646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of underlying risk as a source of heterogeneity in meta-analyses: a simulation study of Bayesian and frequentist implementations of three models.
    Dohoo I; Stryhn H; Sanchez J
    Prev Vet Med; 2007 Sep; 81(1-3):38-55. PubMed ID: 17477995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of meta-analytic results of indirect, direct, and combined comparisons of drugs for chronic insomnia in adults: a case study.
    Vandermeer BW; Buscemi N; Liang Y; Witmans M
    Med Care; 2007 Oct; 45(10 Supl 2):S166-72. PubMed ID: 17909377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Questionable assumptions hampered interpretation of a network meta-analysis of primary care depression treatments.
    Linde K; Rücker G; Schneider A; Kriston L
    J Clin Epidemiol; 2016 Mar; 71():86-96. PubMed ID: 26524496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.